Help the fight against COVID-19

Has a doctor or nurse said you are likely to have COVID-19 infection, or do you have any of these symptoms?

Continuous, new or worsening cough?

High temperature?

Loss or change to your sense of smell or taste?

And did you start to feel unwell in the last 4 days?

Are you aged 18 or over?

Then you could be eligible to join the AGILE trial which aims to find a treatment for people with COVID-19

If you would like to participate in the AGILE trial or find out more then contact your GP or the research team by one of the methods below.

Fill in this form

Or
Tel: 0151 7064863
Text: COVID to 07342 065915
email: [email protected]

You can also visit our sites in Liverpool or Southampton
Clinical Research, Liverpool
Clinical Research, Southampton

More information about treatments being assessed in the AGILE platform study

EIDD-2801. Patient recruitment will begin in Liverpool community hubs, where prospective patients will be contacted by text message, informed about the trial and invited to participate in case they fall ill with COVID-19. You can find more information about EIDD-2801 below, and if you have any further questions, please contact [email protected].

EIDD-2801

VIR-7831/7832. Patient recruitment will begin in Liverpool and Southampton communities, where prospective patients will be contacted by text message, informed about the trial and invited to participate if they have mild to moderate symptoms of COVID-19. You can find more information about VIR-7831/7832 if you have further questions by contacting [email protected]

VIR-7831/7832

Nitazoxanide. Recruitment of healthy volunteers for the first stage of this trial is underway in Liverpool. The second stage of this trial will be carried out in South Africa, recruiting patients with mild/moderate COVID-19 symptoms. You can find more information about Nitazoxanide if you have further questions by contacting [email protected].

Nitazoxanide